<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="self-citation" id="ddr21709-cit-9001">
   <string-name>
    <surname>Sohag</surname>
    <given-names>AAM</given-names>
   </string-name>, 
   <string-name>
    <surname>Hannan</surname>
    <given-names>MA</given-names>
   </string-name>, 
   <string-name>
    <surname>Rahman</surname>
    <given-names>S</given-names>
   </string-name>, et al. 
   <article-title>Revisiting potential druggable targets against 
    <styled-content style="fixed-case" toggle="no">SARS‐CoV</styled-content>‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
   </article-title>. 
   <source xml:lang="en">Drug Dev Res</source>. 
   <year>2020</year>;
   <fpage>1</fpage>–
   <lpage>23</lpage>. 
   <pub-id pub-id-type="doi">10.1002/ddr.21709</pub-id>
  </mixed-citation>
 </p>
 <fn-group>
  <fn id="ddr21709-note-1002">
   <p>
    <bold>Funding information</bold> Ministry of Science, ICT and Future Planning; National Research Foundation of Korea; Korea Research Fellowship Program, Grant/Award Number: 2018H1D3A1A01074712
   </p>
  </fn>
 </fn-group>
</notes>
